GlobeNewswire
-
Helus Pharma to Present Topline Results from Phase 3 APPROACH Study Evaluating HLP003 as Adjunctive Treatment in Major Depressive Disorder on November 16, 2026
15/11/2026 -
Lexeo Therapeutics to Report Third Quarter 2026 Financial Results and Provide LX2020 Business Update on November 16, 2026
15/11/2026 -
Cocrystal Pharma Provides Business Update and Reports Third Quarter 2026 Financial Results
15/11/2026 -
NeuroKaire To Showcase Breakthrough Blood Test That Ends the Antidepressant Guessing Game at HLTH 2026 Conference
15/11/2026 -
Keto-Mojo Unveils World’s First Photoacoustic Breathalyzer, Advancing Non-Invasive Ketone Monitoring
14/11/2026 -
Grassroot Soccer Honors U.S. Soccer at 2026 Gala, Raising over $2 million for Adolescent Health Programs
15/11/2026 -
Prolynx Presents Preclinical Data at ObesityWeek® 2026 Supporting the Potential for Quarterly Dosing of Ultra-Long-Acting Anti-Obesity Peptides
14/11/2026 -
Oban BioPharma Announces Presentation of Late-Breaking Abstract at Obesity Week® 2026
14/11/2026 -
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
14/11/2026 -
TRexBio Reports Third Quarter 2026 Financial Results and Recent Business Highlights
13/11/2026 -
Femasys Announces Financial Results for Quarter Ended September 30, 2026 and Provides Corporate Update
13/11/2026 -
4DMT Announces New Employment Inducement Grants
13/11/2026 -
Indaptus Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
13/11/2026 -
Vistagen Reports Fiscal Year 2027 Second Quarter Financial Results and Provides Corporate Update
13/11/2026 -
Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
13/11/2026 -
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
13/11/2026 -
Natural Alternatives International, Inc. Announces Fiscal 2027 Q1 Results
13/11/2026 -
Cingulate Inc. Reports Third Quarter 2026 Financial Results and Provides Regulatory Update on CTx-1301 NDA Resubmission
13/11/2026 -
Tempest Reports Third Quarter 2026 Financial Results and Provides Business Update
13/11/2026
Pages